Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Fresh insights into how how pig immune system fights flu
"These findings may prove to be crucial for the design of future vaccines against respiratory diseases" - Dr Elma Tchilian.

The findings could lead to new human treatments.

Scientists investigating pigs’ response immune response to influenza have, for the first time, identified specific cells that are crucial in the fight against infection and for providing long-term protection against illness.

In the study, researchers at the Pirbright Institute found four types of T cells that target host cells infected with viruses and kill them to prevent the virus from spreading.

It is hoped that the findings will shed more light on how the human immune system adapts to flu and lead to the development of new vaccines.

Dr Elma Tchilian, head of the mucosal immunology group at Pirbright explains: “These findings may prove to be crucial for the design of future vaccines against respiratory diseases. Tissue resident memory (TRM) cells are important in respiratory diseases such as influenza and COVID-19 and identifying, in detail, where they are located in a relevant animal model is important for our understanding of disease in pigs."

“This knowledge is also highly relevant to human disease. For the first time, we describe the distribution of cells involved in the immune response and their activity over the course of natural infection or vaccination and these are important knowledge gaps to fill.” 

Published in Mucosal Immunology, the study examined the apadative response of CD8 T cells. These are cells that specifically target host cells infected with viruses and kill them to prevent the viruses from spreading.

The team identified four different types of CD8 T cells - naïve, central memory, effector memory and differentiated effector porcine CD8 T cells - and focussed on the tissues where the cells are found. Their results show that the pig immune response is different to that seen in small animals like mice or ferrets, which are not natural hosts for influenza.

The team also revealed the location of D8 T cells in different pig tissues and how they respond to infection. Until now, it was thought that the number of T cells in the lungs declines rapidly after infection, however, this research shows that this is not the case, suggesting longer-lasting protection against future infection. 

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.